Albemarle supplies Dr. Reddy’s
This article was originally published in The Tan Sheet
Albemarle Corp. signs on India-based Dr. Reddy's Laboratories as a non-exclusive distributor of its bulk ibuprofen active pharmaceutical ingredient and to sell and distribute the product within its global client base. Under the terms of the already-in-effect agreement, Baton Rouge, La.-based Albemarle will supply a "substantial quantity" of ibuprofen API for Dr. Reddy's generic ibuprofen tablets, Albemarle says...
You may also be interested in...
Despite AI and digital analytics playing an increasing role in pharma, the industry lags others globally, a recent event heard. Meanwhile, top Indian players including Sun Pharma, Cipla and others shared what is driving their initiatives, ranging from a 'touchless factory' to virtual training and lessons learned along the way.
Hologic made its third big acquisition of 2021 and Agilent agreed to pay up to $695m for Resolution Bioscience to extend its precision oncology capabilities.
Broader than initially reported, Merck & Co.’s agreement with BARDA extends beyond J&J’s recently authorized vaccine to other COVID-19 vaccines and therapeutics as needed.